Richard J. Rubino
2015
In 2015, Richard J. Rubino earned a total compensation of $1.8M as Chief Financial Officer, Secretary at Aerie Pharmaceuticals, a 3% decrease compared to previous year.
Compensation breakdown
| Bonus | $194,554 |
|---|---|
| Option Awards | $985,195 |
| Salary | $375,950 |
| Stock Awards | $254,036 |
| Total | $1,809,735 |
Rubino received $985.2K in option awards, accounting for 54% of the total pay in 2015.
Rubino also received $194.6K in bonus, $376K in salary and $254K in stock awards.
Rankings
In 2015, Richard J. Rubino's compensation ranked 5,128th out of 13,638 executives tracked by ExecPay. In other words, Rubino earned more than 62.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,128 out of 13,638 | 62nd |
Division Manufacturing | 1,894 out of 5,187 | 64th |
Major group Chemicals And Allied Products | 684 out of 1,857 | 63rd |
Industry group Drugs | 544 out of 1,531 | 65th |
Industry Biological Products, Except Diagnostic Substances | 92 out of 260 | 65th |
Source: SEC filing on April 27, 2017.
Rubino's colleagues
We found two more compensation records of executives who worked with Richard J. Rubino at Aerie Pharmaceuticals in 2015.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019